Screening for Brain Metastases in Patients With NSCLC: A Qualitative Study on the Psychologic Impact of Being Diagnosed With Asymptomatic Brain Metastases-Reference-Cited by-同舟云学术

Screening for Brain Metastases in Patients With NSCLC: A Qualitative Study on the Psychologic Impact of Being Diagnosed With Asymptomatic Brain Metastases

Published:2022-10 Issue:10 Volume:3 Page:100401
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Schoenmaekers Janna J.A. O.,Bruinsma Jeroen,Wolfs Claire,Barberio Lidia,Brouns Anita,Dingemans Anne-Marie C.,Hendriks Lizza E.L.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. Brigatinib in crizotinib-refractory ALK+ NSCLC: 2-year follow-up on systemic and intracranial outcomes in the phase 2 ALTA trial;Huber;J Thorac Oncol,2020

2. Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: analysis from the European FRAME study;Moro-Sibilot;Lung Cancer,2015

3. Temporal and gender-related trends in brain metastases from lung and breast cancer;Yawn;Minn Med,2003

4. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

5. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer;Peters;Cancer Treat Rev,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the silent threat: Asymptomatic brain metastasis in non-small-cell lung cancer (NSCLC) patients;Indian Journal of Cancer;2024-01